PDGF-BB prevents destructive repair and promotes reparative osteogenesis of steroid-associated osteonecrosis of the femoral head in rabbits.

[1]  D. Zhao,et al.  Relationship Between Blood Flow and Collapse of Nontraumatic Osteonecrosis of the Femoral Head , 2022, The Journal of bone and joint surgery. American volume.

[2]  Junjie Niu,et al.  Steroid-Induced Osteonecrosis of the Femoral Head: Novel Insight Into the Roles of Bone Endothelial Cells in Pathogenesis and Treatment , 2021, Frontiers in Cell and Developmental Biology.

[3]  Yanqiong Zhang,et al.  General recommendation for assessment and management on the risk of glucocorticoid-induced osteonecrosis in patients with COVID-19 , 2021, Journal of Orthopaedic Translation.

[4]  T. Yuen,et al.  The role of PDGF-BB in the bone-vascular relationship during aging. , 2021, The Journal of clinical investigation.

[5]  Y. Yang,et al.  The effect of genetically modified platelet-derived growth factor-BB over-expressing mesenchymal stromal cells during core decompression for steroid-associated osteonecrosis of the femoral head in rabbits , 2021, Stem cell research & therapy.

[6]  Xu Cao,et al.  Skeleton-derived PDGF-BB mediates arterial stiffening. , 2021, The Journal of clinical investigation.

[7]  Sakae Tanaka,et al.  Femoral head collapse rate among Japanese patients with pre-collapse osteonecrosis of the femoral head , 2021, The Journal of international medical research.

[8]  W. Giannobile,et al.  Recombinant Human Platelet–Derived Growth Factor: A Systematic Review of Clinical Findings in Oral Regenerative Procedures , 2020, JDR clinical and translational research.

[9]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[10]  S. Demehri,et al.  Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development. , 2020, JCI insight.

[11]  Xu Cao,et al.  Glucocorticoids Disrupt Skeletal Angiogenesis Through Transrepression of NF‐κB–Mediated Preosteoclast Pdgfb Transcription in Young Mice , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  Seung-Jae Lim,et al.  Hip resurfacing arthroplasty for osteonecrosis of the femoral head: Implant-specific outcomes and risk factors for failure , 2020, Journal of orthopaedic translation.

[13]  Yi-Xian Qin,et al.  Osteoclastic activity was associated with the development of steroid-induced osteonecrosis of femoral head , 2020, Artificial cells, nanomedicine, and biotechnology.

[14]  Yi Peng,et al.  Type H blood vessels in bone modeling and remodeling , 2020, Theranostics.

[15]  Jiang Peng,et al.  Three-dimensional distribution of cystic lesions in osteonecrosis of the femoral head , 2019, Journal of orthopaedic translation.

[16]  Wei Sun,et al.  The Use of Platelet-Rich Plasma for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review , 2019, BioMed research international.

[17]  Yu-Jie Liang,et al.  PDGF-BB exhibited therapeutic effects on rat model of bisphosphonate-related osteonecrosis of the jaw by enhancing angiogenesis and osteogenesis. , 2019, Bone.

[18]  Kui Zang,et al.  Platelet-derived growth factor B attenuates lethal sepsis through inhibition of inflammatory responses. , 2019, International immunopharmacology.

[19]  Shouan Zhu,et al.  Macrophage-lineage TRAP+ cells recruit periosteum-derived cells for periosteal osteogenesis and regeneration. , 2019, The Journal of clinical investigation.

[20]  Jiang Peng,et al.  Osteogenic magnesium incorporated into PLGA/TCP porous scaffold by 3D printing for repairing challenging bone defect. , 2019, Biomaterials.

[21]  N. Sugano,et al.  Etiologic Classification Criteria of ARCO on Femoral Head Osteonecrosis Part 1: Glucocorticoid-Associated Osteonecrosis. , 2019, Journal of Arthroplasty.

[22]  J. Urbaniak,et al.  Vascular endothelial growth factor for the treatment of femoral head osteonecrosis: An experimental study in canines , 2018, World journal of orthopedics.

[23]  Ping Yang,et al.  Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice. , 2018, Bone.

[24]  Dewei Zhao,et al.  Early diagnosis and treatment of steroid-induced osteonecrosis of the femoral head , 2018, International Orthopaedics.

[25]  J. Griffith,et al.  Blockage of Src by Specific siRNA as a Novel Therapeutic Strategy to Prevent Destructive Repair in Steroid‐Associated Osteonecrosis in Rabbits , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  L. Qin,et al.  Src blockage by siRNA inhibits VEGF-induced vascular hyperpemeability and osteoclast activity - an in vitro mechanism study for preventing destructive repair of osteonecrosis. , 2015, Bone.

[27]  Xin-luan Wang,et al.  Steroid-associated osteonecrosis: Epidemiology, pathophysiology, animal model, prevention, and potential treatments (an overview) , 2015, Journal of Orthopaedic Translation.

[28]  S. Morrison,et al.  Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. , 2014, Cell stem cell.

[29]  P. Gervois,et al.  Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. , 2014, Pharmacology & therapeutics.

[30]  L. Duong,et al.  PDGF-BB secreted by preosteoclasts induces CD31hiEmcnhi vessel subtype in coupling osteogenesis , 2014, Nature Medicine.

[31]  Q. Guo,et al.  Bone Microstructure and Regional Distribution of Osteoblast and Osteoclast Activity in the Osteonecrotic Femoral Head , 2014, PloS one.

[32]  Zi-rong Li,et al.  Relationship between preservation of the lateral pillar and collapse of the femoral head in patients with osteonecrosis. , 2014, Orthopedics.

[33]  Y. Seol,et al.  Dual delivery of rhPDGF-BB and bone marrow mesenchymal stromal cells expressing the BMP2 gene enhance bone formation in a critical-sized defect model. , 2013, Tissue engineering. Part A.

[34]  B. Masri,et al.  Total hip arthroplasty in steroid-induced osteonecrosis: early functional and radiological outcomes. , 2013, Canadian journal of surgery. Journal canadien de chirurgie.

[35]  T. Daniels,et al.  Effect of Implantation of Augment® Bone Graft on Serum Concentrations of Platelet-Derived Growth Factors: A Pharmacokinetic Study , 2013, Clinical Drug Investigation.

[36]  Yuanyuan Zhang,et al.  Coadministration of platelet-derived growth factor-BB and vascular endothelial growth factor with bladder acellular matrix enhances smooth muscle regeneration and vascularization for bladder augmentation in a rabbit model. , 2013, Tissue engineering. Part A.

[37]  P. Esbrit,et al.  Role of angiogenesis on bone formation. , 2012, Histology and histopathology.

[38]  L. Snel,et al.  Safety of recombinant human platelet-derived growth factor-BB in Augment® Bone Graft , 2012, Journal of tissue engineering.

[39]  M. Merchant,et al.  Therapeutic angiogenesis due to balanced single‐vector delivery of VEGF and PDGF‐BB , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  E. Raines,et al.  History of discovery: platelet-derived growth factor. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[41]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[42]  N. Baldini,et al.  Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors , 2011, Acta orthopaedica.

[43]  J. Griffith,et al.  Continuous occurrence of both insufficient neovascularization and elevated vascular permeability in rabbit proximal femur during inadequate repair of steroid-associated osteonecrotic lesions. , 2009, Arthritis and rheumatism.

[44]  N. Sugano,et al.  Distribution of TRAP‐positive cells and expression of HIF‐1α, VEGF, and FGF‐2 in the reparative reaction in patients with osteonecrosis of the femoral head , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[45]  Y. Ishii,et al.  PDGF Receptor β Is a Potent Regulator of Mesenchymal Stromal Cell Function , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[46]  E H Schemitsch,et al.  Fracture vascularity and bone healing: a systematic review of the role of VEGF. , 2008, Injury.

[47]  Kwang Woo Nam,et al.  Fate of untreated asymptomatic osteonecrosis of the femoral head. , 2008, The Journal of bone and joint surgery. American volume.

[48]  David J Mooney,et al.  Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. , 2007, Cardiovascular research.

[49]  A. Flahault,et al.  Corticosteroid‐induced clinical adverse events: frequency, risk factors and patient’s opinion , 2007, The British journal of dermatology.

[50]  Jeffrey R Curtis,et al.  Population-based assessment of adverse events associated with long-term glucocorticoid use. , 2006, Arthritis and rheumatism.

[51]  J. Griffith,et al.  Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone , 2006, Bone.

[52]  A. Nogier,et al.  Fate of very small asymptomatic stage-I osteonecrotic lesions of the hip. , 2004, The Journal of bone and joint surgery. American volume.

[53]  Y. Shoenfeld,et al.  Pathogenesis and natural history of osteonecrosis. , 2002, Seminars in arthritis and rheumatism.

[54]  Gwo‐Jaw Wang,et al.  Risk Period for Developing Osteonecrosis of the Femoral Head in Patients on Steroid Treatment , 2002, Clinical Rheumatology.

[55]  K. Wakabayashi,et al.  Platelet‐Derived Growth Factor BB Secreted From Osteoclasts Acts as an Osteoblastogenesis Inhibitory Factor , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[56]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[57]  H. Plenk,et al.  [Pathomorphological aspects and repair mechanisms of femur head necrosis]. , 2000, Der Orthopade.

[58]  C. Betsholtz,et al.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.

[59]  A. Reddi,et al.  Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects. , 1993, The Journal of clinical investigation.